-
1
-
-
34548040152
-
High throughput solubility measurement in drug discovery and development
-
Alsenz J, Kansy M. (2007). High throughput solubility measurement in drug discovery and development. Adv Drug Deliv Rev, 59:546-567.
-
(2007)
Adv Drug Deliv Rev
, vol.59
, pp. 546-567
-
-
Alsenz, J.1
Kansy, M.2
-
2
-
-
0023947965
-
Pharmaceutical innovation by the seven UK-owned pharmaceutical companies 1964-1985
-
Prentis RA, Lis Y, Walker SR. (1988). Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985). Br J Clin Pharmacol, 25:387-396.
-
(1988)
Br J Clin Pharmacol
, vol.25
, pp. 387-396
-
-
Prentis, R.A.1
Lis, Y.2
Walker, S.R.3
-
3
-
-
0028000096
-
Rationale for the development of Sandimmune Neoral
-
Vonderscher J, Meinzer A. (1994). Rationale for the development of Sandimmune Neoral. Transplant Proc, 26:2925-2927.
-
(1994)
Transplant Proc
, vol.26
, pp. 2925-2927
-
-
Vonderscher, J.1
Meinzer, A.2
-
4
-
-
2442671307
-
Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo
-
Cornaire G, Woodley J, Hermann P, Cloarec A, Arellano C, Houin G. (2004). Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int J Pharm, 278:119-131.
-
(2004)
Int J Pharm
, vol.278
, pp. 119-131
-
-
Cornaire, G.1
Woodley, J.2
Hermann, P.3
Cloarec, A.4
Arellano, C.5
Houin, G.6
-
5
-
-
0037540055
-
Inactive excipients such as Cremophor can affect in vivo drug disposition
-
Wandel C, Kim RB, Stein CM. (2003). 'Inactive' excipients such as Cremophor can affect in vivo drug disposition. Clin Pharmacol Ther, 73:394-396.
-
(2003)
Clin Pharmacol Ther
, vol.73
, pp. 394-396
-
-
Wandel, C.1
Kim, R.B.2
Stein, C.M.3
-
6
-
-
0031914282
-
Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor
-
Hauss DJ, Fogal SE, Ficorilli JV, Price CA, Roy T, Jayaraj AA et al. (1998). Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J Pharm Sci, 87:164-169.
-
(1998)
J Pharm Sci
, vol.87
, pp. 164-169
-
-
Hauss, D.J.1
Fogal, S.E.2
Ficorilli, J.V.3
Price, C.A.4
Roy, T.5
Jayaraj, A.A.6
-
7
-
-
0036741452
-
Effect of nonionic surfactants on membrane transporters in Caco-2 cell monolayers
-
Rege B, Kao J, Polli J. (2002). Effect of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. J Pharm Sci ,16:237-246.
-
(2002)
J Pharm Sci
, vol.16
, pp. 237-246
-
-
Rege, B.1
Kao, J.2
Polli, J.3
-
8
-
-
34548049221
-
Oral lipid-based formulations
-
Hauss D. (2007). Oral lipid-based formulations. Adv Drug Del Rev, 59:667-676.
-
(2007)
Adv Drug Del Rev
, vol.59
, pp. 667-676
-
-
Hauss, D.1
-
9
-
-
80052511398
-
Enhanced oral bioavailability of tacrolimus in rats by selfmicroemulsifying drug delivery systems
-
Yongjun W, Jin S, Tianhong Z, Hongzhuo L, Fancui H, Zhonggui H. (2011). Enhanced oral bioavailability of tacrolimus in rats by selfmicroemulsifying drug delivery systems. Drug Dev Ind Pharmacy, 37(10):1225-1230.
-
(2011)
Drug Dev Ind Pharmacy
, vol.37
, Issue.10
, pp. 1225-1230
-
-
Yongjun, W.1
Jin, S.2
Tianhong, Z.3
Hongzhuo, L.4
Fancui, H.5
Zhonggui, H.6
-
10
-
-
79956355707
-
Influence of co-solvents on the stability and bioavailability of rapamycin formulated in self-microemulsifying drug delivery systems
-
Minghui S, Luqin S, Xuezhen Z, Zhaoze F, Yiming M, Rui Z, Xiangliang Y. (2011). Influence of co-solvents on the stability and bioavailability of rapamycin formulated in self-microemulsifying drug delivery systems. Drug Dev Ind Pharmacy, 37(8):986-994.
-
(2011)
Drug Dev Ind Pharmacy
, vol.37
, Issue.8
, pp. 986-994
-
-
Minghui, S.1
Luqin, S.2
Xuezhen, Z.3
Zhaoze, F.4
Yiming, M.5
Rui, Z.6
Xiangliang, Y.7
-
11
-
-
78650024236
-
Selfmicroemulsifying drug delivery system improves curcumin dissolution and bioavailability
-
Xuemei W, Jianhua X, Xiuwang H, Caixia W. (2011). Selfmicroemulsifying drug delivery system improves curcumin dissolution and bioavailability. Drug Dev Ind Pharmacy, 37(1):15-23.
-
(2011)
Drug Dev Ind Pharmacy
, vol.37
, Issue.1
, pp. 15-23
-
-
Xuemei, W.1
Jianhua, X.2
Xiuwang, H.3
Caixia, W.4
-
12
-
-
78650020977
-
Preparation and evaluation of a self-emulsifying drug delivery system of etoposide-phospholipid complex
-
Zhongbin W, Dan G, Li D, Yue Z, Qiuxia Y, Jianming C. (2011). Preparation and evaluation of a self-emulsifying drug delivery system of etoposide-phospholipid complex. Drug Dev Ind Pharmacy, 37(1):103-112.
-
(2011)
Drug Dev Ind Pharmacy
, vol.37
, Issue.1
, pp. 103-112
-
-
Zhongbin, W.1
Dan, G.2
Li, D.3
Yue, Z.4
Qiuxia, Y.5
Jianming, C.6
-
13
-
-
57349119914
-
Formulation and in vivo evaluation of self-nanoemulsifying granules for oral delivery of a combination of ezetimibe and simvastatin
-
Dixit R, Nagarsenkar M. (2008). Formulation and in vivo evaluation of self-nanoemulsifying granules for oral delivery of a combination of ezetimibe and simvastatin. Drug Dev Ind Pharmacy, 34(12):1285-1296.
-
(2008)
Drug Dev Ind Pharmacy
, vol.34
, Issue.12
, pp. 1285-1296
-
-
Dixit, R.1
Nagarsenkar, M.2
-
14
-
-
80053940463
-
FujicalinR-based fast-dissolving self-emulsifying tablets
-
Myung J, Soo Y, Woo H, Jun S, Sung-Up C, Kyung T, Hyung-Kyoon C,et.al. (2011). FujicalinR-based fast-dissolving self-emulsifying tablets. Drug Dev Ind Pharmacy, 37(11):1298-1305.
-
(2011)
Drug Dev Ind Pharmacy
, vol.37
, Issue.11
, pp. 1298-1305
-
-
Myung, J.1
Soo, Y.2
Woo, H.3
Jun, S.4
Sung-Up, C.5
Kyung, T.6
Hyung-Kyoon, C.7
-
15
-
-
0028353199
-
Cefpodoxime proxetil: A comprehensive review
-
Todd WM. (1994). Cefpodoxime proxetil: A comprehensive review. Int J Antimicrob Agents, 4:37-62.
-
(1994)
Int J Antimicrob Agents
, vol.4
, pp. 37-62
-
-
Todd, W.M.1
-
16
-
-
0037989899
-
Cefpodoxime: Pharmacokinetics and therapeutic uses
-
Chugh K, Agrawal S. (2003). Cefpodoxime: Pharmacokinetics and therapeutic uses. Indian J Pediatr, 70:227-231.
-
(2003)
Indian J Pediatr
, vol.70
, pp. 227-231
-
-
Chugh, K.1
Agrawal, S.2
-
17
-
-
38849151208
-
Preparation and in vivo evaluation of self microemulsified drug delivery system containing fenofibrate
-
Vavia P, Patel A. (2007). Preparation and in vivo evaluation of self microemulsified drug delivery system containing fenofibrate. AAPS Pharm Sci Tech, 9(3): E344-E352.
-
(2007)
AAPS Pharm Sci Tech
, vol.9
, Issue.3
-
-
Vavia, P.1
Patel, A.2
-
18
-
-
0031914282
-
Lipid-based delivery systems for improving bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor
-
Hauss D, Fogal S, Ficorilli J, Price C. (1998). Lipid-based delivery systems for improving bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J Pharm Sci, 87:164-169.
-
(1998)
J Pharm Sci
, vol.87
, pp. 164-169
-
-
Hauss, D.1
Fogal, S.2
Ficorilli, J.3
Price, C.4
-
19
-
-
34548049221
-
Oral lipid-based formulations
-
Hauss DJ. (2007). Oral lipid-based formulations. Adv Drug Deliv Rev, 59:667-676.
-
(2007)
Adv Drug Deliv Rev
, vol.59
, pp. 667-676
-
-
Hauss, D.J.1
-
20
-
-
44849087456
-
Design and evaluation of selfmicroemulsifying drug delivery system (SMEDDS) of tacrolimus
-
Borhade V, Nair H, Hegde D. (2008). Design and evaluation of selfmicroemulsifying drug delivery system (SMEDDS) of tacrolimus. AAPS PharmSciTech, 9:13-21.
-
(2008)
AAPS PharmSciTech
, vol.9
, pp. 13-21
-
-
Borhade, V.1
Nair, H.2
Hegde, D.3
-
23
-
-
0034601204
-
Self-dispersing formulations for improving oral absorption of lipophilic drugs
-
Gershanik T, Benita S. (2000). Self-dispersing formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm, 50:179-188.
-
(2000)
Eur J Pharm Biopharm
, vol.50
, pp. 179-188
-
-
Gershanik, T.1
Benita, S.2
-
24
-
-
0037426719
-
A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS
-
Mu L, Feng SS. (2003). A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. J Control Release, 86:33-48.
-
(2003)
J Control Release
, vol.86
, pp. 33-48
-
-
Mu, L.1
Feng, S.S.2
-
26
-
-
0028194817
-
Self-emulsifying drug delivery systems (SEDDS) with polyglycolized glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs
-
Shah N, Carvajal M et.al. (1994). Self-emulsifying drug delivery systems (SEDDS) with polyglycolized glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm, 106:15-23.
-
(1994)
Int J Pharm
, vol.106
, pp. 15-23
-
-
Shah, N.1
Carvajal, M.2
-
27
-
-
0002556932
-
The First rideal lecture. Microemulsions a field at the border between lyophobic and lyophilic colloids
-
Overbeek J. (1978). The First rideal lecture. Microemulsions, a field at the border between lyophobic and lyophilic colloids. Faraday Discuss Chem Soc, 65:7-19.
-
(1978)
Faraday Discuss Chem Soc
, vol.65
, pp. 7-19
-
-
Overbeek, J.1
-
28
-
-
57449109685
-
Design and optimization of a new self-nanoemulsifying drug delivery system
-
Wang L, Dong J, Chen J, Eastoe J, Li X. (2009). Design and optimization of a new self-nanoemulsifying drug delivery system. J Colloid Interface Sci, 330:443-448.
-
(2009)
J Colloid Interface Sci
, vol.330
, pp. 443-448
-
-
Wang, L.1
Dong, J.2
Chen, J.3
Eastoe, J.4
Li, X.5
-
29
-
-
84875897746
-
-
Available at (Accessed on 20.11.
-
Available at: http://www.antareshealthproducts.com/about-tpgs/properties. html (Accessed on 20.11.2011).
-
(2011)
-
-
-
30
-
-
84875879178
-
-
In: Shah DO, ed., Macro- and microemulsions. Washington DC:American Chemistry Soceity
-
Sharma M, Shiao S, Bansal V, Shah D. (1985). Effect of chain length compatibility on monolayers, foams and Macro- and Microemulsions. In: Shah DO, ed., Macro- and microemulsions. Washington DC:American Chemistry Soceity, 87-103.
-
(1985)
Effect of chain length compatibility on monolayers, foams and Macro- and Microemulsions
, pp. 87-103
-
-
Sharma, M.1
Shiao, S.2
Bansal, V.3
Shah, D.4
-
33
-
-
0034601204
-
Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs
-
Gershanik T, Benita S. (2000). Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm, 50:179-188.
-
(2000)
Eur J Pharm Biopharm
, vol.50
, pp. 179-188
-
-
Gershanik, T.1
Benita, S.2
-
36
-
-
0029120281
-
Unusual dissolution behavior of cefpodoxime proxetil: Effect of pH and ionic factors STP
-
Hamamura T, Ohtani T, Kusai A, Nishimura K. (1995). Unusual dissolution behavior of cefpodoxime proxetil: Effect of pH and ionic factors.S.T.P. Pharm Sci, 5:332-338.
-
(1995)
Pharm Sci
, vol.5
, pp. 332-338
-
-
Hamamura, T.1
Ohtani, T.2
Kusai, A.3
Nishimura, K.4
-
37
-
-
33745504614
-
Decrease in dissolution of cefpodoxime proxetil tablets by gel formation and its improvement
-
Hamamura T, Terashima H, Ohtani T, et.al. (1995). Decrease in dissolution of cefpodoxime proxetil tablets by gel formation and its improvement. Yakuzaigaku,55:175-182.
-
(1995)
Yakuzaigaku
, vol.55
, pp. 175-182
-
-
Hamamura, T.1
Terashima, H.2
Ohtani, T.3
-
38
-
-
0030950491
-
Cefpodoxime proxetil esterase activity in rabbit small intestine: Role in the partial cefpodoxime absorption
-
Crauste-Manciet S, Huneau J, Decroix M, Tome D, Chaumeil J. (1997). Cefpodoxime proxetil esterase activity in rabbit small intestine: Role in the partial cefpodoxime absorption. Int J Pharm, 149:241-249.
-
(1997)
Int J Pharm
, vol.149
, pp. 241-249
-
-
Crauste-Manciet, S.1
Huneau, J.2
Decroix, M.3
Tome, D.4
Chaumeil, J.5
-
39
-
-
33745514646
-
Investigation of factors responsible for low oral bioavailability of cefpodoxime proxetil
-
Kakumanu VK, Arora V, Bansal AK. (2006). Investigation of factors responsible for low oral bioavailability of cefpodoxime proxetil. Int J Pharm, 317:155-160.
-
(2006)
Int J Pharm
, vol.317
, pp. 155-160
-
-
Kakumanu, V.K.1
Arora, V.2
Bansal, A.K.3
-
40
-
-
2442671307
-
Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo
-
Cornaire G, Woodley J, Hermann P. (2004). Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int J Pharm, 278:4022-4031.
-
(2004)
Int J Pharm
, vol.278
, pp. 4022-4031
-
-
Cornaire, G.1
Woodley, J.2
Hermann, P.3
-
41
-
-
0037540055
-
Inactive excipients such as Cremophor can affect in vivo drug disposition
-
Wandel C, Kim R, Stein M. (2003) Inactive excipients such as Cremophor can affect in vivo drug disposition. Clin Pharmacol Ther, 73(5):394-396.
-
(2003)
Clin Pharmacol Ther
, vol.73
, Issue.5
, pp. 394-396
-
-
Wandel, C.1
Kim, R.2
Stein, M.3
-
42
-
-
0031914282
-
Lipid-based delivery systems for improving bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor
-
Hauss D, Fogal S, Ficorilli J, Price C.(1998). Lipid-based delivery systems for improving bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J Pharm Sci, 87: 164-169.
-
(1998)
J Pharm Sci
, vol.87
, pp. 164-169
-
-
Hauss, D.1
Fogal, S.2
Ficorilli, J.3
Price, C.4
-
43
-
-
0036741452
-
Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers
-
Rege BD, Kao JP, Polli JE. (2002). Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur J Pharm Sci, 16:237-246.
-
(2002)
Eur J Pharm Sci
, vol.16
, pp. 237-246
-
-
Rege, B.D.1
Kao, J.P.2
Polli, J.E.3
|